insights_auto
Prečo akcie MRNA klesli 5,00%?
Preskúmať podrobnejšiechevron_right
MRNA:NASDAQ
Moderna Inc
213,74 USD
arrow_downward
-5,00%(-11,26) 1 d.
212,51 USD
arrow_downward
-0,58% (-1,23)bedtimePo uzavretí
Zavreté: 12. 10., 16:00:02 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre MRNA…
Otvoriť
224,50 USD
Vysoká
227,46 USD
Nízka
210,91 USD
Trh. kap.
85,33 mld.
Priem. obj.
17,01 mil.
Objem
12,87 mil.
Max. za 52 týž.
227,46 USD
Min. za 52 týž.
22,29 USD
Výnosy na akciu
-7,98 USD
Beta
1,09
Akcie v obehu
399,24 mil.
Počet zamestnancov
5 tis.
Otvoriť
224,50 USD
Vysoká
227,46 USD
Nízka
210,91 USD
Trh. kap.
85,33 mld.
Priem. obj.
17,01 mil.
Objem
12,87 mil.
Max. za 52 týž.
227,46 USD
Min. za 52 týž.
22,29 USD
Výnosy na akciu
-7,98 USD
Beta
1,09
Akcie v obehu
399,24 mil.
Počet zamestnancov
5 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Simply Wall Street
·
pred 42 minútami
Moderna Stock Puts MRNA Cancer Vaccine Shares Back In Focus
Zacks
·
pred 2 hodinami
Here's Why Moderna (MRNA) Fell More Than Broader Market
TradingKey
·
pred 5 hodinami
Moderna Inc Stock (MRNA) Moved Down by 5.73% on Oct 12: Facts Behind the Movement
Benzinga
·
pred 7 hodinami
10 Health Care Stocks With Whale Alerts In Today’s Session
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Informácie o subjekte Moderna Inc
Generálny riaditeľStéphane Bancel
Zamestnanci4,7 tis.
Dátum založeniasep 2010
Hlavné sídlo-
Odvetvie-